DE60330454D1 - Spheniscins und analoge antimikrobielle peptide zur konservierung von lebensmitteln - Google Patents

Spheniscins und analoge antimikrobielle peptide zur konservierung von lebensmitteln

Info

Publication number
DE60330454D1
DE60330454D1 DE60330454T DE60330454T DE60330454D1 DE 60330454 D1 DE60330454 D1 DE 60330454D1 DE 60330454 T DE60330454 T DE 60330454T DE 60330454 T DE60330454 T DE 60330454T DE 60330454 D1 DE60330454 D1 DE 60330454D1
Authority
DE
Germany
Prior art keywords
arg
phe
gly
ser
spheniscins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60330454T
Other languages
English (en)
Inventor
Philippe Bulet
Cecile Thouzeau
Maho Yvon Le
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of DE60330454D1 publication Critical patent/DE60330454D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE60330454T 2002-07-01 2003-07-01 Spheniscins und analoge antimikrobielle peptide zur konservierung von lebensmitteln Expired - Lifetime DE60330454D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0208207A FR2841556B1 (fr) 2002-07-01 2002-07-01 Peptides ayant des proprietes antimicrobiennes et les compositions les contenant notamment pour la conservation des aliments
PCT/FR2003/002041 WO2004003006A2 (fr) 2002-07-01 2003-07-01 Peptides antimicrobiens pour la conservation des aliments

Publications (1)

Publication Number Publication Date
DE60330454D1 true DE60330454D1 (de) 2010-01-21

Family

ID=29725047

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60330454T Expired - Lifetime DE60330454D1 (de) 2002-07-01 2003-07-01 Spheniscins und analoge antimikrobielle peptide zur konservierung von lebensmitteln

Country Status (10)

Country Link
US (1) US7384911B2 (de)
EP (1) EP1517916B1 (de)
JP (1) JP4410100B2 (de)
AT (1) ATE451114T1 (de)
AU (1) AU2003264679A1 (de)
CA (1) CA2492053C (de)
DE (1) DE60330454D1 (de)
ES (1) ES2337999T3 (de)
FR (1) FR2841556B1 (de)
WO (1) WO2004003006A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4113957B2 (ja) * 2002-06-19 2008-07-09 アムコア ファーマ， インコーポレイテッド テトラフルオロベンジル誘導体及びこれを含有する急性及び退行性脳神経系疾患の予防及び治療用薬学的組成物
EP2010561A4 (de) * 2006-04-27 2010-03-24 Singapore Health Services Pte Antimikrobielle peptide
NZ593653A (en) 2008-07-18 2012-09-28 Novozymes Adenium Biotech As Treatment of inflammatory bowel diseases with mammal beta defensins
KR101249702B1 (ko) 2010-06-16 2013-04-05 주식회사 나이벡 항균 또는 항염증 활성을 가지는 펩타이드 및 이를 유효성분으로 함유하는 약제학적 조성물
CN102229666B (zh) * 2011-05-27 2013-04-17 山东迅达康兽药有限公司 动物源型阳离子抗菌肽的制备方法及其应用
ES2637286T3 (es) 2011-07-08 2017-10-11 Defensin Therapeutics Aps Tratamiento oral de la enfermedad inflamatoria intestinal
WO2013026794A1 (en) * 2011-08-19 2013-02-28 Novozymes Novel immunomodulatory peptide
AR089615A1 (es) * 2012-12-28 2014-09-03 Consejo Nac Invest Cient Tec Peptidos antimicrobianos, composiciones que los comprenden y usos
CN103554244B (zh) 2013-05-09 2016-09-07 香雪集团(香港)有限公司 具有抑制呼吸道病毒感染的活性的肽及其应用和制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635594A (en) * 1994-03-11 1997-06-03 University Of California, Los Angeles Gallinacins - antibiotic peptides
CA2264203A1 (en) * 1996-08-22 1998-02-26 The Trustees Of The University Of Pennsylvania Compositions and methods for use of defensin
ATE442041T1 (de) * 2000-07-28 2009-09-15 Murphy Christopher J Medium für transplantat

Also Published As

Publication number Publication date
JP2006513136A (ja) 2006-04-20
WO2004003006A2 (fr) 2004-01-08
JP4410100B2 (ja) 2010-02-03
WO2004003006A3 (fr) 2004-04-08
CA2492053C (fr) 2014-04-08
FR2841556A1 (fr) 2004-01-02
US20050245437A1 (en) 2005-11-03
AU2003264679A8 (en) 2004-01-19
AU2003264679A1 (en) 2004-01-19
ES2337999T3 (es) 2010-05-03
FR2841556B1 (fr) 2007-07-20
EP1517916A2 (de) 2005-03-30
ATE451114T1 (de) 2009-12-15
EP1517916B1 (de) 2009-12-09
US7384911B2 (en) 2008-06-10
CA2492053A1 (fr) 2004-01-08

Similar Documents

Publication Publication Date Title
DE69321118D1 (de) Peptide und Proteine, Verfahren zur Ihren Herstellung und die Verwendung als Cholesterol-Annehmer
CY1113684T1 (el) Anti-mikρobiaka πεπτιδια που περιλαμβανουν μια αργινινη (arginine)- kai/ή λυσινη (lysine)- που περιεχουν υποκινητη
ATE169304T1 (de) Biologisch aktive peptide aus funktionellen domaenen des bakteriziden/ die permeabilitaet erhoehenden proteins und ihre verwendung
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
NO20011386D0 (no) Nye metoder for fremvisning av (poly)peptider/proteiner pÕ bakteriofage partikler via disulfidbindinger
DK1521774T3 (da) Trunkerede Tau-proteiner
DE60330454D1 (de) Spheniscins und analoge antimikrobielle peptide zur konservierung von lebensmitteln
DE60126966D1 (de) Tgf-beta inhibitoren und methoden
DE60335640D1 (de) Polypeptide der gh-61-familie
ATE278710T1 (de) Antimikrobiell wirksame peptide
ATE211391T1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
AR024742A1 (es) DERIVADOS CICLOPEPTIDICOS QUE ACTUAN COMO INHIBIDORES DE LA INTEGRINA ALFA v BETA 6, LOS MEDICAMENTOS A BASE DE ESTOS COMPUESTOS, LAS COMPOSICIONESFARMACEUTICAS QUE CONTIENEN AL MENOS UNO DE ESTOS MEDICAMENTOS, Y EL EMPLEO DE ESTOS PEPTIDOS PARA PREPARAR UN MEDICAMENTO.
ATE481420T1 (de) Il-21-derivate
Poulter et al. Levitide, a neurohormone-like peptide from the skin of Xenopus laevis. Peptide and peptide precursor cDNA sequences.
HK1088016A1 (en) Isolated fluorescent protein from clytia gregaria cgfp and use thereof
DE60039049D1 (de) Erhöhte expression von proteinen mittels gfp
DE50212280D1 (de) Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren
WO2002055669A3 (en) Regulation of target protein activity through modified proteins
DE69832299D1 (de) Einkettigen polypeptiden enthalten troponin i und troponin c
ATE82984T1 (de) Hemmende peptide.
HUP0301523A2 (hu) VEGF-peptidek és alkalmazásuk angiogenezis gátlására
BRPI0715331B8 (pt) polipeptídeo que compreende uma porção n-terminal e uma porção c-terminal, e uso do mesmo
ATE346091T1 (de) Neues diagnostisches reagens und kit zur erkennung von rickettsiose
CA2530731A1 (en) Peptide having apoptosis-inhibiting activity
DE60141948D1 (de) Zur steuerung der parkinaktivität brauchbare zusammensetzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition